The $13 billion total joint market is facing a number of challenges coming off the recent recession.
Although the demographics related to joint replacement remain strong, manufacturers continue to be plagued by downward pressure on implant prices, a slowdown in procedure volumes, and an ongoing shift in hospital purchasing. Many believe that J&J's recent acquisition of Synthes will spark a wave of consolidation in the industry.
by Sharon O'Reilly and Lisa Mahan
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
